The incidence of malignant lymphoma and multiple myeloma in Hiroshima and Nagasaki atomic bomb survivors, 1945–1965
The present study demonstrates an increased prevalence of malignant lymphoma and multiple myeloma in survivors of the atomic bomb in Hiroshima exposed to 100 rad or more; a similar relationship is not evident in Nagasaki. This apparent discrepancy is tentatively attributed to known physical differences in the radiation spectrum emitted by the 2 bombs and/or biological differences between the inhabitants of Hiroshima and Nagasaki. Other observations of interest include the following: the risk of developing lymphoma or multiple myeloma appears to be greater in persons exposed at less than 25 years of age than in people who were 25 or more years old at the time of the bomb; the appearance time is shorter in the younger age group exposed to 100 rad or more in comparison with less heavily exposed persons, and also in comparison with heavily exposed persons in the older age groups. (auth)
- Research Organization:
- Originating Research Org. not identified
- Sponsoring Organization:
- USDOE
- NSA Number:
- NSA-29-010407
- OSTI ID:
- 4404723
- Journal Information:
- Cancer (Philadelphia), Vol. 32, Issue 6; Other Information: Orig. Receipt Date: 30-JUN-74; ISSN 0008-543X
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Similar Records
Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow
Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987
Related Subjects
*A-BOMB SURVIVORS- DELAYED RADIATION EFFECTS
*LYMPHOMAS- RADIOINDUCTION
*NEOPLASMS- RADIOINDUCTION
*RADIATION INJURIES- AGE DEPENDENCE
BIOLOGICAL RADIATION EFFECTS
HIROSHIMA
NAGASAKI
NUCLEAR EXPLOSIONS
RADIATION DOSES
RADIATION HAZARDS RADIOINDUCTION